Skip to main content
Year archive

HLB INC. — 2026 filings

All 24 regulatory filings released by HLB INC. (028300) in 2026, sourced directly from the official regulator.

24 Filings
2026 Period
2026 filings (24)
Filing Released Lang
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-04-21 Korean
전환가액의조정
Capital/Financing Update
2026-04-16 Korean
증권발행결과(자율공시)
Capital/Financing Update
2026-04-15 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2026-04-07 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-31 Korean
대표이사변경
Board/Management Information
2026-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-31 Korean
기업설명회(IR)개최
Investor Presentation
2026-03-25 Korean
기업설명회(IR)개최
Investor Presentation
2026-03-25 Korean
사업보고서 (2025.12)
Audit Report / Information FY 2025
2026-03-23 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-23 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-03-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2026-03-12 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2026-03-09 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-03-04 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2026-03-03 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2025
2026-02-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2026-02-26 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-02-26 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-02-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-02-19 Korean
기타경영사항(자율공시) (HLB 간암 1차 치료제(리보세라닙,캄렐리주맙 병용요법) FDA에 재승인 서류 제출)
Regulatory Filings
2026-01-26 Korean
전환가액의조정
Capital/Financing Update
2026-01-16 Korean